AppropriationsSenate Committee Approves 4.5 Percent Cut to Defense Dept. Cancer Research FundingBy Tessa Vellek The Department of Defense appropriations measure for the fiscal year 2015, approved by the Senate Appropriations Committee July 17, decreased overall funding for peer-reviewed cancer research programs by 4.5 percent. The committee recommended adjusting DoD’s health research budget to $120 million for breast cancer research, $64 million for prostate cancer research, $10 million for ovarian cancer research, and $50 million for the peer-reviewed cancer research program that would research cancers not addressed in the aforementioned programs, according to the Senate report. The breast cancer program will see no changes from the current fiscal year, but both prostate cancer research and ovarian cancer research were slated for decreases in funding of 20 percent and 50 percent, respectively. There was no mention of a lung cancer research program in the Senate’s report for the next fiscal year, although in fiscal year 2014 the program received $10.5 million. Nine cancers are eligible to compete for the funding provided through the $50 million adjustment: colorectal cancer, kidney cancer, liver cancer, melanoma, mesothelioma, myelproliferative disorders, neuroblastoma, pancreatic cancer, and stomach cancer. The House has not acted on its version of the spending bill. The House report, dated June 13, recommends $120 million for breast cancer research, $80 million for prostate cancer research, $20 million for ovarian cancer research, $10.5 million for lung cancer research, and $15 million for the peer-reviewed cancer research program that would research cancers not addressed in the aforementioned programs.
In the past, Michael Symon has said he won't open another Cleveland restaurant that mimics his mission at Lola Bistro. His next spot, Mabel's BBQ, takes a whole new direction for Cleveland's Iron Chef: Restaurant Row.
LeBron isn’t the only one who's returning. Last fall, my husband and I left our house in the suburbs and moved to Cleveland. We live in the largest residential development built in the city since World War II. It is a haven of new construction nestled in a zip code that saw one of the highest foreclosure rates in the country. You don’t...
Investigators at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute are developing a novel, multistep investigational treatment for one of the most complex and difficult-to-treat forms of the disease, locally advanced pancreatic cancer.